83 studies found for:    Open Studies | "Lacrimal Apparatus Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Lacrimal Apparatus Diseases" (83 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: euphrasia based homeopathic therapy and cyclosporin;   Drug: cyclosporin solution
2 Recruiting Civamide Nasal Solution for Dry Eye
Condition: Dry Eye
Intervention: Drug: Civamide Nasal Spray
3 Recruiting Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
Condition: Dry Eye Syndromes
Interventions: Drug: cyclosporine 0.05% ophthalmic emulsion;   Drug: carboxymethylcellulose-based lubricant eye drops
4 Recruiting Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects
Condition: Dry Eye
Interventions: Drug: Propylene Glycol, 0.6% eye drops;   Drug: Preservative-free 0.9% Saline solution
5 Not yet recruiting Examining the Immunological Process of Autoimmune Patients
Conditions: Sjogren's Syndrome;   Autoimmune Diseases;   Dry Eyes;   Dry Mouth
Intervention:
6 Recruiting Rebamipide for the Treatment of Xerostomia in sjögren Syndrome
Condition: Improving Symptoms of Dry Mouth in Sjőgren's Syndrome
Intervention: Drug: Rebamipide
7 Unknown  Treatment of Salivary Gland Hypofunction With Neuro- Electrostimulation
Conditions: Xerostomia;   Polypharmacy;   Sjögren's Syndrome
Interventions: Device: Automatic neuro-electrostimulation by "Saliwell Crown";   Device: Patient-regulated neuro-electrostimulation by "Saliwell Crown"
8 Recruiting A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: carboxymethylcellulose 0.5%/glycerin 0.9%;   Drug: sodium hyaluronate 0.18%
9 Not yet recruiting Changes in Tear Osmolarity Over Time With Sustained Use of TheraTears
Condition: Dry Eye Syndrome
Intervention: Other: TheraTears lubricating drops
10 Recruiting Effects of Sustained Reading on the Ocular Surface
Conditions: Dry Eye Syndromes;   Sjogren's Syndrome
Intervention:
11 Recruiting Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
Condition: Dry Eye Disease
Interventions: Drug: P-321 Ophthalmic Solution;   Drug: P-321 Ophthalmic Solution placebo
12 Unknown  Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye
Conditions: Dry Eye;   Sjogren's Syndrome;   Graft vs. Host Disease
Intervention: Drug: Thymosin Beta 4 eye drops vs. vehicle
13 Recruiting PD of VAY736 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: VAY736;   Drug: Placebo
14 Recruiting Ocular Surface Immune Response in Dry Eye Disease: Analysis of Conjunctival and Peripheral Corneal Immune Cell Alterations by In Vivo Confocal Microscopy and Clinical Correlation
Condition: Dry Eye Disease
Intervention: Other: In vivo confocal microscopy (IVCM)
15 Unknown  The Pathogenesis of Idiopathic Dry Eyes
Conditions: Dry Eye;   Fibromyalgia
Intervention:
16 Unknown  Tears Substitutions and Their Effects on Higher Order Aberrometery
Condition: Dry Eye Syndrome
Interventions: Other: Preservative Free Saline;   Other: Optive;   Other: Refresh Moderate/Severe;   Other: Systane;   Other: Systane Ultra
17 Unknown  A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Condition: Dry Eye Syndrome
Intervention: Drug: Essential fatty acid supplement
18 Recruiting Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
Condition: Primary Sjögren's Syndrome (pSS)
Interventions: Drug: Tocilizumab;   Drug: Placebo
19 Recruiting Multi-Colored Placido Disk Viability
Conditions: Dry Eye;   Sjogren's Disease;   Healthy
Intervention: Procedure: Multi-colored Placido disk imaging
20 Recruiting Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye
Condition: Dry Eye Syndrome.
Interventions: Biological: Human nerve growth factor 20 µg/mL;   Biological: Human nerve growth factor 4 µg/mL or 60 µg/mL

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years